SCHEMBL13633450

SCHEMBL13633450

CSc1nc(Cl)cc(NC(=O)OC(C)(C)C)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
GAA P10253 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ADORA3 P0DMS8 2/20 0.41
ADORA2A P29274 2/20 0.41
SCN9A Q15858 1/20 0.41
ATR Q13535 1/20 0.39
PPARA Q07869 3/20 0.38
RXRA P19793 2/20 0.38
RXRB P28702 2/20 0.38
PPARG P37231 2/20 0.38
POLB P06746 1/20 0.38
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
LCK P06239 3/20 0.37
STK17B O94768 1/20 0.36
STK17A Q9UEE5 1/20 0.36
HTT P42858 1/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16308071 0.82 MEN1 (0.47) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL4443611 0.81 LCK (0.41) MEN1KMT2ASCN9AATRGSK3B
SCHEMBL3280779 0.80 ADORA3 (0.56) MEN1KMT2AGAASMN1; SMN2ADORA3
SCHEMBL3804329 0.79 HSP90AA1 (0.47) KMT2AGAASMN1; SMN2SCN9AATR
SCHEMBL31248850 0.79 ATR (0.45) SCN9AATRGSK3BDYRK1ALCK
SCHEMBL16147173 0.79 ATR (0.45) SCN9AATRGSK3BDYRK1ALCK
SCHEMBL16308051 0.79 MEN1 (0.44) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL21287207 0.78 LCK (0.40) ADORA3SCN9AATRGSK3BDYRK1A
SCHEMBL14801498 0.77 MEN1 (0.62) MEN1KMT2AGAASMN1; SMN2PPARA
SCHEMBL4438011 0.77 ATF1 (0.42) SCN9AATRPOLBGSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295729-A Carboxy-benzimidazole GLP-1R modulating compounds 吉利德科学公司 2023-12-26 CN disclosed
CN-117279905-A Carboxy-benzimidazole GLP-1R modulating compounds 吉利德科学公司 2023-12-22 CN disclosed
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
EP-1737459-B1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2009-08-05 EP disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191394-A1 Antibacterial agents MRPL21, RPN2, FBL MEN1 2732/4885KMT2A 4819/4885GAA 91/4885
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA MEN1 3353/4885KMT2A 4669/4885GAA 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.